ESTRADERM TTS 100 price in UAE

Overview

Welcome to Dwaey, specifically on ESTRADERM TTS 100 Patches/Transdermal page.
This medicine contains an important and useful components, as it consists of Estradiol.
ESTRADERM TTS 100 is available in the market in concentration 8mg/Patch and in the form of Patches/Transdermal.

CIBA GEIGY is the producer of ESTRADERM TTS 100 and it is imported from SWITZERLAND, The most popular alternatives of ESTRADERM TTS 100 are listed downward .

Mode Of Action

Estradiol is a naturally occurring oestrogen. Oestrogens are responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. They modulate the pituitary secretion of gonadotrophins, LH and FSH through a negative feedback system.

Indication

Moderate to severe vasomotor symptoms associated with menopause
Prophylaxis of osteoporosis in postmenopausal women
Hypogonadism
Atrophic vaginitis

Precaution

Conditions exacerbated by fluid retention; hypercalcaemia, cerebrovascular diorders, coronary artery disease, gall bladder diseases; lipid effects; familial defects of lipoprotein metabolism. May increase BP, risk of venous thromboembolism, breast cancer, benign hepatic adenoma, endometrial cancer and size of preexisting uterine leiomyomata. Dosage should be reduced in hepatic impairment. Lactation. Child. Lactation: Drug enters breast milk; use with caution

Side Effects

Anxiety
Abdominal cramping
Amenorrhea
Bloating
Breakthrough bleeding
Breast enlargement
Breast tenderness
Delayed ejaculation
Depression
Dry mouth
Headache
Hypertension
Impotency
Influenza
Leukorrhea
Melasma
Muscle cramps
Nausea
Nervousness
Peripheral edema
Polydipsia
Pruritus
Rash
Swelling
Spotting
Syncope
Toothache
Vaginal discomfort
vaginal erosion
vaginal ulceration
adherence of the vaginal ring to the vaginal wall (Estring)
Vomiting
Weight changes

Contra indication

Hypersensitivity; undiagnosed vag bleeding; thrombophloebitis or thromboembolic disorders; breast carcinoma except in selected patients being treated for metastatic disease; oestrogen-dependent tumor; porphyria; pregnancy.

Pregnancy and lactation

Pregnancy category: X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.

Interaction

CYP1A2 and CYP3A4 inducers e.g. aminoglutethimide, carbamazepine, phenobarbital, and rifampin may decrease the effects of estradiol. May enhance the effects of hydrocortisone and prednisolone when used together.